Novartis India Q4 net falls 26 pc to Rs 20 cr

Last Updated : May 23 2019 | 6:36 PM IST

Drug firm Novartis India Thursday reported 26.21 per cent decline in net profit at Rs 19.53 crore for the quarter ended March 31, 2019.

The company posted a profit of Rs 26.47 crore in the year-ago period, Novartis India said in a BSE filing.

Revenue from operations for the latest quarter stood at Rs 110.38 crore as against Rs 125.32 crore in the same period of 2017-18.

For the entire 2018-19, net profit was Rs 51.77 crore as compared to Rs 78.36 crore during the previous year.

Revenue from operations for the last fiscal stood at Rs 490.68 crore as against Rs 563.89 crore in 2017-18.

The company's board has recommended a dividend of 200 per cent (Rs 10 per equity share of Rs 5 each) for the year ended March 31, 2019.

Shares of Novartis India settled at Rs 716.75 apiece on BSE, up 0.85 per cent, over its previous close.

Disclaimer: No Business Standard Journalist was involved in creation of this content

Already subscribed? Log in

^*Subscribe to Business Standard digital and get complimentary access to The New York Times

3 Months

₹300/Month

SAVE 25%

1 Year

₹225/Month

SAVE 46%

*Complimentary New York Times access for the 2nd year will be given after 12 months

2 Years

₹162/Month

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

SAVE 25%